ask="24.75"
ask_size="300"
average_daily_volume="438150"
bid="N/A"
bid_size="N/A"
book_value="8.12"
change="+0.06"
change_from_200_day_moving_average="-0.78"
change_from_50_day_moving_average="-0.75"
change_from_52_week_high="-5.09"
change_From_52_week_low="7.88"
change_in_percent="+0.31%"
close="19.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="-18.48M"
eps_estimate_current_year="-0.11"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-0.01"
ex_dividend_date="N/A"
float_shares="21579000"
high="19.99"
high_52_weeks="24.57"
last_trade_date="3/9/2017"
last_trade_price="19.48"
last_trade_size="19124"
last_trade_time="4:00pm"
low="18.97"
low_52_weeks="11.60"
market_capitalization="742.05M"
moving_average_200_day="20.26"
moving_average_50_day="20.23"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="33.33"
open="19.55"
pe_ratio="N/A"
peg_ratio="-9.15"
percent_change_from_200_day_moving_average="-3.85%"
percent_change_from_50_day_moving_average="-3.72%"
percent_change_from_52_week_high="-20.72%"
percent_change_from_52_week_low="+67.93%"
previous_close="19.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.39"
price_per_sales="5.54"
revenue="133.59M"
shares_outstanding="38093000"
short_ratio="16.58"
stock_exchange="NGM"
symbol="RTRX"
volume="634420"
weeks_range_52="11.60 - 24.57"
